Inactivation of the 20S proteasome maturase, Ump1p, leads to the instability of mtDNA in Saccharomyces cerevisiae.
The proteasome plays fundamental roles in the removal of oxidized proteins and in normal degradation of short-lived proteins. Increasing evidence suggests that the proteasome may be an important factor in both oxidative stress response and cellular aging. Moreover, it was recently reported that proteasome inhibition leads to mitochondrial dysfunction. In this study, we have investigated whether proteasome impairment, caused by deletion of UMP1, a gene necessary for the 20S proteasome biogenesis, may influence the stability of the yeast mitochondrial genome. Here we show that an ump1Delta mutant displays enhanced mitochondrial point mutagenesis, measured by the frequency of oligomycin-resistant (Oli(r)) and erythromycin-resistant (Ery(r)) mutants, compared to that of the isogenic wild-type strain. Deletion of UMP1 significantly increases also the frequency of respiration-defective mutants having gross rearrangements of the mitochondrial genome. We show that this mitochondrial mutator phenotype of the ump1Delta strain is considerably reduced in the presence of a plasmid encoding Msh1p, the mitochondrial homologue of the bacterial mismatch protein MutS, which was shown previously to counteract oxidative lesion-induced instability of mtDNA. In search of the mechanism underlying the decreased stability of mtDNA in the ump1Delta deletion mutant, we have determined the level of reactive oxygen species (ROS) in the mutant cells and have found that they are exposed to endogenous oxidative stress. Furthermore, we show also that both cellular and intramitochondrial levels of Msh1p are significantly reduced in the mutant cells compared to the wild-type cells. We conclude, therefore, that both an increased ROS production and a markedly decreased level of Msh1p, a protein crucial for the repair of mtDNA, lead in S. cerevisiae cells with impaired proteasome activity to the increased instability of their mitochondrial genome.
Malc
Ewa
E
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Dzierzbicki
Piotr
P
Kaniak
Aneta
A
Skoneczna
Adrianna
A
Ciesla
Zygmunt
Z
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015152:Blotting, Northern; D015153:Blotting, Western; D015825:Chromosomes, Fungal / Q000235:genetics; D004271:DNA, Fungal / Q000235:genetics; D004272:DNA, Mitochondrial / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D025141:Drug Resistance, Fungal; D004917:Erythromycin / Q000494:pharmacology; D016681:Genome, Fungal; D054629:Genome, Mitochondrial; D008928:Mitochondria / Q000235:genetics* / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000235:genetics / Q000378:metabolism; D018832:Molecular Chaperones / Q000037:antagonists & inhibitors* / Q000235:genetics* / Q000378:metabolism; D009154:Mutation / Q000235:genetics; D009840:Oligomycins / Q000494:pharmacology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D010641:Phenotype; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012441:Saccharomyces cerevisiae / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development; D029701:Saccharomyces cerevisiae Proteins / Q000235:genetics / Q000378:metabolism
D000900:Anti-Bacterial Agents; D004271:DNA, Fungal; D004272:DNA, Mitochondrial; D004268:DNA-Binding Proteins; C078660:MSH1 protein, S cerevisiae; D024101:Mitochondrial Proteins; D018832:Molecular Chaperones; D009840:Oligomycins; D012333:RNA, Messenger; D017382:Reactive Oxygen Species; D029701:Saccharomyces cerevisiae Proteins; C110856:proteasome maturation protein; D004917:Erythromycin; D046988:Proteasome Endopeptidase Complex